APA (7th ed.) Citation

Nolte, F., & Hofmann, W. (2015). Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome: Emphasis on optimized dosing schedules and new formulations. Leukemia research, 39(10), . https://doi.org/10.1016/j.leukres.2015.06.008

Chicago Style (17th ed.) Citation

Nolte, Florian, and Wolf-Karsten Hofmann. "Updated Recommendations on the Management of Gastrointestinal Disturbances During Iron Chelation Therapy with Deferasirox in Transfusion Dependent Patients with Myelodysplastic Syndrome: Emphasis on Optimized Dosing Schedules and New Formulations." Leukemia Research 39, no. 10 (2015). https://doi.org/10.1016/j.leukres.2015.06.008.

MLA (9th ed.) Citation

Nolte, Florian, and Wolf-Karsten Hofmann. "Updated Recommendations on the Management of Gastrointestinal Disturbances During Iron Chelation Therapy with Deferasirox in Transfusion Dependent Patients with Myelodysplastic Syndrome: Emphasis on Optimized Dosing Schedules and New Formulations." Leukemia Research, vol. 39, no. 10, 2015, https://doi.org/10.1016/j.leukres.2015.06.008.